Companies Dominating the Histamine Toxicity Landscape
- Johnson and Johnson company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Mylan Laboratories Ltd
- Neogen Corporation
- Pfizer Inc
- Travere Therapeutics, Inc.
- Alembic pharmaceuticals
- Intas Pharmaceuticals Ltd
- Sanofi Aventis Ltd
- Cipla Limited
- Actavis Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of histamine toxicity is estimated at USD 440.18 million.
The histamine toxicity market size was valued at USD 421.2 million in 2024 and is likely to cross USD 824.25 million by 2037, registering more than 5.3% CAGR during the forecast period i.e., between 2025-2037. Growing consumption of seafood, poor refrigeration & rotten fish will boost the market growth.
North America industry is poised to account for largest revenue share of 33% by 2037, due to rising substantial consumption of seafood and canned fish in the region.
The major players in the market are Travere Therapeutics, Inc., Alembic pharmaceuticals, Intas Pharmaceuticals Ltd, Sanofi Aventis Ltd, Cipla Limited, Actavis Inc., and others.
